Nivolumab (N) plus low-dose ipilimumab (I) vs platinum-doublet chemotherapy (Chemo) as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (NSCLC): Checkmate 227 part 1 final analysis Meeting Abstract
| Authors: | Reck, M.; Peters, S.; Ramalingam, S.; Paz-Ares, L.; Caro, R. B.; Zurawski, B.; Kim, S. W.; Alexandru, A.; Lupinacci, L.; Jitnenez, E. D.; Sakai, H.; Albert, I.; Vergnenegre, A.; Borghaei, H.; Brahmer, J. R.; O'Byrne, K.; Geese, W. J.; Bhagavatheeswaran, P.; Nattan, F. E.; Hellmann, M. D. |
| Abstract Title: | Nivolumab (N) plus low-dose ipilimumab (I) vs platinum-doublet chemotherapy (Chemo) as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (NSCLC): Checkmate 227 part 1 final analysis |
| Meeting Title: | 34. Deutscher Krebskongress (DKK) |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 43 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Feb 19-22 |
| Meeting Location: | Berlin, Germany |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2020-02-01 |
| Start Page: | 233 |
| End Page: | 234 |
| Language: | English |
| ACCESSION: | WOS:000517158700580 |
| PROVIDER: | wos |
| DOI: | 10.1159/000506491 |
| Notes: | "34th German Cancer Congress" -- Meeting Abstract: 1008 -- Source: Wos |
